Barrington lowered the firm’s price target on Stoneridge (SRI) to $16 from $20-$25 and keeps an Outperform rating on the shares. The company’s Q3 came in weaker than expected and 2024 guidance was reduced as market challenges continue, the analyst tells investors in a research note.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks